UB Paderborn / Katalog / Suche / in CDI

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Annals of oncology, 2019-03, Vol.30 (3), p.418-423

2019

Link zum Volltext

Verfügbarkeit prüfen

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

Annals of oncology, 2019-06, Vol.30 (6), p.921-926

2019

Link zum Volltext

Verfügbarkeit prüfen

A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

Annals of oncology, 2018-10, Vol.29, p.viii63-viii63

2018

Link zum Volltext

Verfügbarkeit prüfen

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

Annals of oncology, 2018-10, Vol.29, p.viii58-viii59

2018

Link zum Volltext

Verfügbarkeit prüfen

Sentinel lymph node biopsy and Axillary dissection in breast cancer : Results in a large series

JNCI : Journal of the National Cancer Institute, 1999-02, Vol.91 (4), p.368-373

1999

Link zum Volltext

Verfügbarkeit prüfen

First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER+/HER2- early breast cancer (BC) patients

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi31

2017

Link zum Volltext

Verfügbarkeit prüfen

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC)

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi27

2017

Link zum Volltext

Verfügbarkeit prüfen

Separate cavity margins excision as a complement to conservative breast cancer surgery

European journal of surgical oncology, 2010-07, Vol.36 (7), p.632-638

2010

Link zum Volltext

Verfügbarkeit prüfen

8746 POSTER Could Hypertension Be a Potential Biomarker in Patients With Recurrent Glioblastoma Treated With Antiangiogenic Drugs? -a Retrospective Analysis

European journal of cancer (1990), 2011, Vol.47, p.S587-S587

2011

Link zum Volltext

Verfügbarkeit prüfen

Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up

Pathologica, 2012-12, Vol.104 (6), p.428

2012

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneity of ER, PgR, HER2 and Ki67 in multifocal/multicentric breast cancer with a single histotype and same grade: implications for pathologists and oncologists from a large multi-institutional series

European journal of cancer (1990), 2024-03, Vol.200, p.113619, Article 113619

2024

Link zum Volltext

Verfügbarkeit prüfen

Choroid Plexus and Aquaporin-1: A Novel Explanation of Cerebrospinal Fluid Production

Pediatric neurosurgery, 2004-11, Vol.40 (6), p.277-283

2004

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

Journal of clinical oncology, 2003-01, Vol.21 (2), p.266-272

2003

Link zum Volltext

Verfügbarkeit prüfen

Prediction of response to primary chemotherapy for operable breast cancer

European journal of cancer (1990), 1999-04, Vol.35 (4), p.574-579

1999

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-08-04: PD-L1 expression and prognosis in triple negative breast cancer (TNBC): An analysis of 265 patients (pts) treated with standard therapy for stage I-III disease

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-08-04

2019

Link zum Volltext

Verfügbarkeit prüfen

19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study

Annals of oncology, 2020-05, Vol.31, p.S23-S23

2020

Link zum Volltext

Verfügbarkeit prüfen

Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia

Seminars in diagnostic pathology, 2001-11, Vol.18 (4), p.267

2001

Link zum Volltext

Verfügbarkeit prüfen

Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody

Modern pathology, 2004-05, Vol.17 (5), p.547-552

2004

Link zum Volltext

Verfügbarkeit prüfen

Evidence of Epstein-Barr virus infection in ulcerative colitis

Digestive and liver disease, 2001-10, Vol.33 (7), p.551-558

2001

Link zum Volltext

Verfügbarkeit prüfen

ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model

Annals of oncology, 2017-09, Vol.28, p.v63-v63

2017

Link zum Volltext

Verfügbarkeit prüfen

New Immunohistochemical Markers Predictive of Response to Neoadjuvant Chemotherapy Plus Trastuzumab in HER2-Positive Locally Advanced Breast Cancer: A Single Center Experience

Annals of oncology, 2012-09, Vol.23, p.ix124

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-05-20: Tumor infiltrating lymphocytes in recurrent HER2+ and triple negative breast cancer: Prognostic value according to tumor phenotype

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-05-20

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-12-06: Factors related to the prognosis of breast cancer patients after the development of brain metastases

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-12-06

2017

Link zum Volltext

Verfügbarkeit prüfen

Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients

Cancer, 1999-06, Vol.85 (11), p.2433-2438

1999

Link zum Volltext

Verfügbarkeit prüfen

First prospective multicenter Italian study on the impact of the 21-gene recurrence score® (RS) in adjuvant clinical decisions for ER + /HER2- early breast cancer patients

Annals of oncology, 2016-10, Vol.27, p.vi53-vi53

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

Sentinel lymph node biopsy and Axillary dissection in breast cancer : Results in a large series

First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER+/HER2- early breast cancer (BC) patients

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC)

Separate cavity margins excision as a complement to conservative breast cancer surgery

8746 POSTER Could Hypertension Be a Potential Biomarker in Patients With Recurrent Glioblastoma Treated With Antiangiogenic Drugs? -a Retrospective Analysis

Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up

Heterogeneity of ER, PgR, HER2 and Ki67 in multifocal/multicentric breast cancer with a single histotype and same grade: implications for pathologists and oncologists from a large multi-institutional series

Choroid Plexus and Aquaporin-1: A Novel Explanation of Cerebrospinal Fluid Production

Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

Prediction of response to primary chemotherapy for operable breast cancer

Abstract P4-08-04: PD-L1 expression and prognosis in triple negative breast cancer (TNBC): An analysis of 265 patients (pts) treated with standard therapy for stage I-III disease

19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study

Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia

Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody

Evidence of Epstein-Barr virus infection in ulcerative colitis

ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model

New Immunohistochemical Markers Predictive of Response to Neoadjuvant Chemotherapy Plus Trastuzumab in HER2-Positive Locally Advanced Breast Cancer: A Single Center Experience

Abstract P2-05-20: Tumor infiltrating lymphocytes in recurrent HER2+ and triple negative breast cancer: Prognostic value according to tumor phenotype

Abstract P1-12-06: Factors related to the prognosis of breast cancer patients after the development of brain metastases

Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients

First prospective multicenter Italian study on the impact of the 21-gene recurrence score® (RS) in adjuvant clinical decisions for ER + /HER2- early breast cancer patients

Suchergebnisse filtern